Christian Rommel
CIK: 0002022449
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRSP
CRISPR Therapeutics AG
Director
Discretionary Trading P&L
Holdings
About Rommel Christian
Rommel Christian (SEC CIK 0002022449) files insider reports with the SEC as Director of CRISPR Therapeutics AG (CRSP).
Signal8 holds 2 ownership filings by Rommel Christian, all Form 4s, filed between Jun 6, 2025 and Jun 9, 2026. Those filings report 2 transactions, from Jun 5, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rommel Christian's filings is in BOSTON, MA.
Recent filings by Rommel Christian
Other insiders filing for CRISPR Therapeutics AG (CRSP)
- Sakhamuri Sivakesava, Chief Technical Officer
- Silver Andrew Jacob, Chief Financial Officer
- KASINGER JAMES R., General Counsel and Secretary
- Kulkarni Samarth, Chief Executive Officer
- Patel Naimish, Chief Medical Officer
- George Simeon, Director